201 related articles for article (PubMed ID: 30763392)
1. Discrimination of breast cancer from benign tumours using Raman spectroscopy.
Lyng FM; Traynor D; Nguyen TNQ; Meade AD; Rakib F; Al-Saady R; Goormaghtigh E; Al-Saad K; Ali MH
PLoS One; 2019; 14(2):e0212376. PubMed ID: 30763392
[TBL] [Abstract][Full Text] [Related]
2. Identification of Molecular Basis for Objective Discrimination of Breast Cancer Cells (MCF-7) from Normal Human Mammary Epithelial Cells by Raman Microspectroscopy and Multivariate Curve Resolution Analysis.
Iwasaki K; Araki A; Krishna CM; Maruyama R; Yamamoto T; Noothalapati H
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466869
[TBL] [Abstract][Full Text] [Related]
3. The use of Au@SiO2 shell-isolated nanoparticle-enhanced Raman spectroscopy for human breast cancer detection.
Zheng C; Liang L; Xu S; Zhang H; Hu C; Bi L; Fan Z; Han B; Xu W
Anal Bioanal Chem; 2014 Sep; 406(22):5425-32. PubMed ID: 24958347
[TBL] [Abstract][Full Text] [Related]
4. Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS).
Gebrekidan MT; Erber R; Hartmann A; Fasching PA; Emons J; Beckmann MW; Braeuer A
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782532. PubMed ID: 29991340
[TBL] [Abstract][Full Text] [Related]
5. Raman spectra exploring breast tissues: comparison of principal component analysis and support vector machine-recursive feature elimination.
Hu C; Wang J; Zheng C; Xu S; Zhang H; Liang Y; Bi L; Fan Z; Han B; Xu W
Med Phys; 2013 Jun; 40(6):063501. PubMed ID: 23718612
[TBL] [Abstract][Full Text] [Related]
6. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
[TBL] [Abstract][Full Text] [Related]
7. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
10. A Molecular Typing Method for Invasive Breast Cancer by Serum Raman Spectroscopy.
Jiang J; Li L; Yin G; Luo H; Li J
Clin Breast Cancer; 2024 Jun; 24(4):376-383. PubMed ID: 38492997
[TBL] [Abstract][Full Text] [Related]
11. Studying the pathological and biochemical features in breast cancer progression by confocal Raman microspectral imaging of excised tissue samples.
Wang S; Li H; Ren Y; Yu F; Song D; Zhu L; Yu S; Jiang S; Zeng H
J Photochem Photobiol B; 2021 Sep; 222():112280. PubMed ID: 34375907
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.
McLaren BK; Gobbi H; Schuyler PA; Olson SJ; Parl FF; Dupont WD; Page DL
Am J Surg Pathol; 2005 Jan; 29(1):105-8. PubMed ID: 15613861
[TBL] [Abstract][Full Text] [Related]
13. The lipid-reactive oxygen species phenotype of breast cancer. Raman spectroscopy and mapping, PCA and PLSDA for invasive ductal carcinoma and invasive lobular carcinoma. Molecular tumorigenic mechanisms beyond Warburg effect.
Surmacki J; Brozek-Pluska B; Kordek R; Abramczyk H
Analyst; 2015 Apr; 140(7):2121-33. PubMed ID: 25615557
[TBL] [Abstract][Full Text] [Related]
14. Raman spectroscopy of blood plasma samples from breast cancer patients at different stages.
Nargis HF; Nawaz H; Ditta A; Mahmood T; Majeed MI; Rashid N; Muddassar M; Bhatti HN; Saleem M; Jilani K; Bonnier F; Byrne HJ
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117210. PubMed ID: 31176149
[TBL] [Abstract][Full Text] [Related]
15. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
16. Exploring type II microcalcifications in benign and premalignant breast lesions by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS).
Liang L; Zheng C; Zhang H; Xu S; Zhang Z; Hu C; Bi L; Fan Z; Han B; Xu W
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():397-402. PubMed ID: 24887501
[TBL] [Abstract][Full Text] [Related]
17. Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma.
Shabaik A; Lin G; Peterson M; Hasteh F; Tipps A; Datnow B; Weidner N
Diagn Cytopathol; 2011 May; 39(5):328-32. PubMed ID: 21488175
[TBL] [Abstract][Full Text] [Related]
18. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
19. Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting.
Luangxay T; Virachith S; Hando K; Vilayvong S; Xaysomphet P; Arounlangsy P; Phongsavan K; Mieno MN; Honma N; Kitagawa M; Sawabe M
Asian Pac J Cancer Prev; 2019 Feb; 20(2):589-594. PubMed ID: 30806064
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
